These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3951148)

  • 41. Combined modality therapy in the treatment of esophageal cancer.
    Ilson DH; Kelsen DP
    Semin Oncol; 1994 Aug; 21(4):493-507. PubMed ID: 8042047
    [No Abstract]   [Full Text] [Related]  

  • 42. [Case of 5-year survival in a surgical case of esophageal cancer of the cervico-thoracic region with pre-operative radiotherapy].
    Ishigami K; Matsuo Y; Matsumoto T
    Shujutsu; 1969 Nov; 23(11):1479-86. PubMed ID: 5366072
    [No Abstract]   [Full Text] [Related]  

  • 43. [Prognosis and preoperative irradiation in the surgery of esophageal cancer].
    Hirata K; Izuka T; Mitomi T; Ishikawa S; Mikuriya S
    Kyobu Geka; 1968 Nov; 21(11):821-4. PubMed ID: 5752346
    [No Abstract]   [Full Text] [Related]  

  • 44. [Indications for the surgical and combined treatments of cancer of the thoracic portion of the esophagus].
    Masiukova EM; Tun VG
    Vestn Khir Im I I Grek; 1980 Oct; 125(10):70-3. PubMed ID: 6162266
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Discussional comments apropos of Prof. A. A. Rusanov's article entitled "Basic principles of surgical treatment of esophageal neoplasms"].
    Pirogov AI; Gritsman IuI; Mamontov AS
    Khirurgiia (Mosk); 1975 Dec; (12):79-84. PubMed ID: 1223406
    [No Abstract]   [Full Text] [Related]  

  • 46. [Clinicopathological studies on preoperative adjuvant cancer chemotherapy by one shot infusion into the esophageal artery for the treatment of esophageal cancer--with special reference to histopathological effects].
    Matsuno M
    Igaku Kenkyu; 1984 Mar; 54(2):134-49. PubMed ID: 6207699
    [No Abstract]   [Full Text] [Related]  

  • 47. [Combined preoperative 60Co radiation and surgery for middle-third esophageal carcinoma--an analysis of 323 cases].
    Zhang YD
    Zhonghua Zhong Liu Za Zhi; 1985 May; 7(3):203-6. PubMed ID: 4017847
    [No Abstract]   [Full Text] [Related]  

  • 48. [Current status of combined modality therapy for esophageal cancer: from the standpoint of medical oncology].
    Ohtsu A
    Gan To Kagaku Ryoho; 1998 Jan; 25(2):232-40. PubMed ID: 9474933
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Adjuvant therapy of esophageal cancer--preoperative irradiation].
    Kajisa T; Suenaga T; Nishi M
    Nihon Kyobu Geka Gakkai Zasshi; 1978 Mar; 26(3):343-5. PubMed ID: 701888
    [No Abstract]   [Full Text] [Related]  

  • 50. Myelotoxicity of preoperative chemoradiotherapy is a significant determinant of poor prognosis in patients with T4 esophageal cancer.
    Miyoshi N; Yano M; Takachi K; Kishi K; Noura S; Eguchi H; Yamada T; Miyashiro I; Ohue M; Ohigashi H; Sasaki Y; Ishikawa O; Doki Y; Imaoka S
    J Surg Oncol; 2009 Apr; 99(5):302-6. PubMed ID: 19170110
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma.
    Mariette C; Taillier G; Van Seuningen I; Triboulet JP
    Ann Thorac Surg; 2004 Oct; 78(4):1177-83. PubMed ID: 15464466
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Surgical treatment of esophageal cancer.
    Knisely JP; Burtness BA; Salem RR
    N Engl J Med; 2003 Mar; 348(12):1177-9; author reply 1177-9. PubMed ID: 12647729
    [No Abstract]   [Full Text] [Related]  

  • 53. Toxicity of chemotherapy for esophageal carcinoma.
    Ilson D
    Chest Surg Clin N Am; 1997 Aug; 7(3):551-63; discussion 564. PubMed ID: 9246402
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic significance of vascular endothelial growth factor and cyclooxygenase 2 expression in patients receiving preoperative chemoradiation for esophageal cancer.
    Kulke MH; Odze RD; Mueller JD; Wang H; Redston M; Bertagnolli MM
    J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1579-86. PubMed ID: 15173710
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cancer of the gastroesophageal junction: combined modality therapy.
    Ilson DH
    Surg Oncol Clin N Am; 2006 Oct; 15(4):803-24. PubMed ID: 17030275
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Radioimmunoassay of carcinoembryonic antigen, gastrin and immunoglobulin E in evaluating different methods of treatment of patients with esophageal and stomach cancer].
    Parkhomenko AV; Chebotareva ED; Okulov LV
    Med Radiol (Mosk); 1984 Nov; 29(11):9-12. PubMed ID: 6503653
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Approaches to improving the methods of treating esophageal cancer].
    Kochegarov AA
    Vopr Onkol; 1984; 30(9):50-4. PubMed ID: 6495694
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Advantages and limits on the surgical therapy of esophageal cancer].
    Abo S; Kudo T; Nakamura M; Maeda K; Tsuji K; Hashimoto M; Izumi K; Gan K; Watanabe K
    Gan No Rinsho; 1984 Jul; 30(9 Suppl):1035-40. PubMed ID: 6471406
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Palliative treatment of esophageal and cardial carcinoma].
    Norberto L; Ranzato R; Erroi F; Marino S; Bardini R; Angriman I; Corti L; Donadi M; D'Erminio A; Vella V; Tropea A; D'Amico DF
    Minerva Chir; 1999 Oct; 54(10):647-55. PubMed ID: 10575886
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of preoperative chemotherapy for esophageal cancer: when is surgery alone feasible?
    Chong G; Cunningham D
    Nat Clin Pract Oncol; 2005 Apr; 2(4):172-3. PubMed ID: 16264912
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.